Cost-effectiveness analysis: out of touch with clinical reality?
Maetzel
Andreas
A
D018501:Antirheumatic Agents / Q000191:economics* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans
D018501:Antirheumatic Agents